3 results
The primary objective is to evaluate the safety and effectiveness of FIRM-guided procedures in addition to conventional ablation for the treatment of persistent or paroxysmal atrial fibrillation (AF) in repeat ablation procedures.The secondary…
Currently, all rotigotine transdermal patches are manufactured at 1 manufacturing site. A second site has been built to manufacture the same patches. Before these patches may be used, it needs to be investigated if they are exactly the same as those…
PART B (FL phase IIb *PARADIGME*):Primary objective:Randomised section of Part B- To evaluate the efficacy of the *40/15* dose regimen (40 mg lilotomab / 15 MBq/kg Betalutin) compared with *100/20* dose regimen (100 mg/m2 lilotomab/ 20 MBq/kg…